Dow Jones Newswires: Chinese drug makers’ shares plunge as Pfizer’s Paxlovid gains market share

Shares of Chinese pharmaceutical companies plunged Tuesday morning on Chinese bourses, continuing a slide that began in the face of competition from Pfizer’s COVID-19 drug Paxlovid earlier this month.

Previous post Hit by climate change, farmers in Cambodia are risking everything on microfinance loans
Next post China turns to lemons, peaches and traditional medicine in wake of Covid wave